Clofenciclan
From Wikipedia, the free encyclopedia
Not to be confused with Clofenamide.
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
2-[1-(4-chlorophenyl)cyclohexyl]oxy-N,N-diethylethanamine
|
|
| Clinical data | |
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 5632-52-0  |
| ATC code | none |
| PubChem | CID 25904 |
| ChemSpider | 24135 |
| UNII | P4BVX0D2MX |
| ChEMBL | CHEMBL2106084  |
| Chemical data | |
| Formula | C18H28ClNO |
| Molar mass | 309.874 |
|
|
|
|
| (what is this?) (verify) |
Clofenciclan (Chlorphencyclan; Tonquil, Vesitan) is a dopamine-releasing agent developed by Boehringer & Soehne in the 1950s.[1] It proved unpopular as a treatment because of its pronounced stimulant activity.[2]
References[edit]
- ^ U.S. Patent 3,254,083
- ^ Poeldinger W. Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry. (German). Praxis. 1962 Jan 18;51:73-8. PMID 14487367
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
